Molecular mechanisms of testicular carcinogenesis

World Journal of Urology

Volumn 14, Issue 5, 1996, Pages 347-352

  Rukstalis, D B ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RNA;

ANIMAL; CYTOGENETICS; GENETICS; GENOME IMPRINTING; HUMAN; MALE; MOLECULAR BIOLOGY; PATHOLOGY; REVIEW; STEM CELL; TESTIS TUMOR;

ANIMALS; CYTOGENETICS; DNA, NEOPLASM; GENOMIC IMPRINTING; HUMANS; MALE; MOLECULAR BIOLOGY; RNA, NEOPLASM; STEM CELLS; TESTICULAR NEOPLASMS;

EID: 0030341318     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00184608     Document Type: Article

References (45)

1. Akin NB (1973) High chromosomal numbers of seminomata and malignant teratomata of the testis: a review of data on 103 tumours. Br J Cancer 28:275-279
2. Atkin NB, Baker MC (1991) Numerical chromosomal changes in 165 malignant tumors. Cancer Genet Cytogenet 52:113121
3. Bartkova J, Bartek J, Lukas J. Vojtesek B, Staskova Z, Reijhat A, Kovarik J, Midgley CA, Lane DP (1991) p53 protein interactions in human testicular cancer including pre-invasive intratubular germ cell neoplasia. Int J Cancer 49: 196-202
4. Bosl GJ, Dmitrovsky E, Reuter VE, Samaniego F, Rodriguez E, Geller NL, Chaganti RSK (1989) Isochromosome of chromosome 12: clinically useful marker for male germ cell tumors. J Natl Cancer 81:1874-1878
5. Clermont Y (1972) Kinetics of spermatogenesis in mammals: seminiferous epithelium cycle and spermatogonal renewal. Physiol Rev 52: 198-236
6. De Wolf WC, Lange PH, Emerson M, Yunis EJ (1979) HLA and testicular cancer. Nature 277:216-217
7. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel IS, Bradley A (1992) Mice deficient for p53 are developmentally normal but sesceptible to spontaneous tumors. Nature 356:215-221
8. Giwercman A, Carlsen E, Keiding N, Skakkebaek NE (1993) Evidence for increasing incidence of abnormalities of the human testis: a review. Environ Health Perspect 101 [Suppl 2]: 65-71
9. Kademian MT, Caldwell WL (1976) Testicular seminoma: a case report of 2 brothers with seminoma and a review of the literature of testicular malignancies occurring in closely related family members. J Urol fl6:380-381
10. Kouzarides T (1995) Transcriptional control by the retinoblastoma protein. Semin Cancer Biol 6:91-98
11. Kratzik C, Aiginger P, Kuber W, Riccabona M, Kuhrer I, Joos H, Frick J, Amman G, Mayr W ( 1991 ) Risk factors for bilateral germ cell tumors: does heredity play a role? Cancer 68:916921
12. Lamb DL (1993) Growth factors and testicular development. J Urol 150:583-592
13. Looijenga LHJ, Abraham M, Gillis AJM, Saunders GF, Oosterhuis JW (1994) Testicular germ cell tumors of adults show deletions of chromosomal bands 1 Ipl3 and 1 Ipl5, but no abnormalities within the zincfinger regions and exons 2 and 6 of the Wilm's tumor 1 gene. Genes Chromosomes Cancer 9: 153160
14. Lothe RA, Fossa SD, Stenwig AE, Nakamura Y, White R, Borreson AL, Brogger A (1989) Loss of 3p or lip alleles is associated with testicular cancer tumors. Genomics 5: 134-138
15. Manova K, Bachvarova RF (1991) Expression of c-kit encoded at the W locus of mice in developing embryonic germ cells and presumptive melanoblasts. Dev Biol 146:312-324
16. Mathew S, Murty WS, Bosi GJ, Chaganti RSK (1994) Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. Cancer Res 54:6265-6269
17. Mikuloski P, Oldbring J (1992) Microinvasive germ cell neoplasia of the testis. Cancer 70:659-664
18. Mulder MP, Keijzer W, Verkerk A, Boot AJ, Prins NE, Splinter TA, Bos JL (1989) Activated ras genes in human seminoma: evidence for tumor heterogeneity. Oncogene 4:1345-1351
19. Murty WS, Dmitrovsky E, Bosl G, Chaganti RSK (1990) Nonrandom chromosomal abnormalities in testicular and ovarian germ cell tumor cell lines. Cancer Genet Cytogenet 50:67-73
20. Murty WS, Houldsworth J, Baldwin S, Reuter V, Hunziker W, Besmer P, Bosl G, Chaganti RSK (1992) Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors. PNAS 89 : 11006-11010
21. Murty WS, Bosl GJ, Houldsworth J, Meyers M, Mukherjee AB, Reuter V, Chaganti RSK (1994) Allelic loss and somatic differentiation in human germ cell tumors. Oncogene 9:22452251
22. Nichols CR, Heerema NA, Palmer C, Loehrer PJ, Williams SD, Einhorn LH (1987) Klinefelter's syndrome associated with mediastinal germ cell neoplasms. J Clin Oncol 5: 12901294
23. Nicholson PW, Harland SJ (1995) Inheritance and testicular cancer. Br J Cancer 71:421-4126
24. Nocka K, Majumber S, Chabot B, Ray P, Cervone M, Bernstein A, Besmer P (1989) Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice - evidence for an impaired c-kit kinase in mutant mice. Genes Dev 3:816-826
25. Noguchi T, Noguchi M (1985) A recessive mutation (ter) causing germ cell deficiency and a high incidence of congenital testitular teratomas in 129/Sv-ter mice. J Natl Cancer Insl 75: 385-392
26. Ogawa O, Eccles MR, Szeto J, et al. (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumor. Nature 362:749-751
27. Peltomaki P, Alfthan O, Chapelle A de la ( 1991 ) Oncogenes in human testicular cancer: DNA and RNA studies. Br J Cancer 63:851-858
28. Peltomaki P, Lothe RA, Borresen AL. Fossa SD, Brogger A. Chapelle A de la (1992) Chromosome 12 in human testicular cancer: dosage changes and their parental origin. Cancer Genet Cytogenet 64:21-26
29. Peng H-Q, Hogg D, Malkin D, Bailey D, Gallic BL, Bulbul M, Jewett M, Buchanan J, Goss PE (1993) Mutations of the p53 gene do not occur in testis cancer. Cancer Res 53:3574-3578
30. Rainier S, Feinberg AP (1994) Genomic imprinting, DNA methyiation, and cancer. J Natl Cancer Inst 86:753-759
31. Reinberg Y, Manivel JC, Zhang G, Reddy PK ( 1991 ) Synchronous bilateral testicular germ cell tumors of different histologie type. Cancer 68: 1082-1085
32. Rukstalis DB, Bubley GJ, Donahue JP, Richie JP, Seidman JG, De Wolf WC (1989) Regional loss of chromosome 6 in two urologie malignancies. Cancer Res 49:5087-5090
33. Sikora K, Evan G, Stewart J, Watson JV (1985) Detection of the c-myc oncogene product in testicular cancer. Br J Cancer 52:171-176
34. Skakkebaek NE, Berthelsen JG, Giwercman A, Muller J (1987) Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumors except spermatocytoma. Int J Androl 10: 19-28
35. Smith RC, Rukstalis DB (1995) Frequent loss of heterozygosity at 1 Ip loci in testicular cancer. J Urol 153:1684-1687
36. Sorrentino V, Giorgi M, Geremia R, Besmer P, Rossi P (1991) Expression of the c-kit protooncogene in the murine male germ cells. Oncogene 6:149-151
37. Strohmeyer T, Peter S, Hartmann M, Munemitsu S, Ackerman R, Ulrich A, Slamon DJ (1991) Expression of the hst-1 and ckit protooncogenes in human testicular germ cell tumors. Cancer Res 51 : 1811-1816
38. Strohmeyer T, Klone A, Wagner G, Hartmann M, Sies H (1992) Glutathione S-transferases in human testicular germ cell tumors: changes of expression and activity. J Urol 147: 1424-1428
39. Strohmeyer T, Reissmann P, Cordon-Cardo C, Hartmann M, Ackermann R, Slamon D (1991) Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. PNAS 88:6662-6666
40. Strohmeyer T, Reese D, Press M, Ackerman R, Hartmann M, Slamon D (1995) Expression of the c-kit protooncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. J Urol 153:511-515
41. Tan JC, Nocka K, Ray P, Traktman P, Besmer P (1990) The dominant W42 "spotting phenotype results from a missense mutation in the c-kit receptor kinase. Science 247:209-247
42. Van Gurp RJHLM, Oosterhuis JW, Kalscheuer V, Mariman ECM, Looijenga LHJ (1994) Biallelic expression of the H19 and IGF 2 genes in human testicular germ cell tumors. J Natl Cancer Inst 86:1070-1075
43. Wang L, Vass W, Gao C, Chang KSS (1987) Amplification and enhanced expression of the c-Ki-ras 2 proto-oncogene in human embryonal carcinomas. Cancer Res 47:4192-4-198
44. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70: 937-948
45. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu RY, Birkett NC, Okino KH, Murdock DC, Jacobsen FW, Langley KE, Smith KA, Takeishi T, Cattanach BM, Galli SJ, Suggs SV (1990) Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the ckit tyrosine kinase receptor. Cell 63:213-224